Patent ID: 6884792
Filing Date: 2005-04-26
Classification: A61K

Abstract:
1. A pharmaceutical combination useful for preventing and/or treating a cardiovascular condition, the pharmaceutical combination comprising: a bretylium cation or a source of a bretylium cation; an acetylsalicylate anion or a source of an acetylsalicylate anion; and a β-receptor blocker or a source of a β-receptor blocker, said acetylsalicylate anion comprising a compound of the structure: wherein: R R said bretylium cation or said source of a bretylium cation, said acetylsalicylate anion or source of an acetylsalicylate anion, and said β-receptor blocker or said source of a β-receptor blocker together are present in said pharmaceutical combination in a therapeutically effective amount.